Deniz Lengerli

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 3

Top Topics

Structure Activity Relationship

Capillary Electrophoresis

Childhood Cancer

Molecular Docking

Top Venues

Expert opinion on drug discovery

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Sümeyye Turanlı, Esra Nalbat, Deniz Lengerli, Kubra Ibis, Sezen Güntekin Ergün, Ece Akhan Güzelcan, Mesut Muyan, Rengul Cetin-Atalay, Burcu Çalışkan, Erden Banoglu
Vicinal Diaryl-Substituted Isoxazole and Pyrazole Derivatives with In Vitro Growth Inhibitory and In Vivo Antitumor Activity. ACS omega 7 (41) (2022)
Deniz Lengerli, Kubra Ibis, Yahya Nural, Erden Banoglu
The 1,2,3-triazole 'all-in-one' ring system in drug discovery: a good bioisostere, a good pharmacophore, a good linker, and a versatile synthetic tool. Expert opinion on drug discovery (2022)
Ozge Akbulut-Caliskan, Deniz Lengerli, Ozge Saatci, Elif Duman, Urartu Özgür Şafak Şeker, Aynur Isik, Aytekin Akyol, Burcu Caliskan, Erden Banoglu, Özgür Sahin
A Highly Potent TACC3 Inhibitor as a Novel Anticancer Drug Candidate. Molecular cancer therapeutics 19 (6) (2020)